Life Sci Cos. Should Prep For Enforcement After COVID Pause - Law360

John Cunningham, shareholder in the firm's White Collar Defense, Compliance & Investigations group, Linda Pissott Reig, shareholder and co-chair of the firm's FDA practice and George Karavetsos, shareholder in the firm’s FDA & Biotechnology and White Collar, Compliance & Investigations practices, co-authored an article for Law360 entitled, “Life Sci Cos. Should Prep For Enforcement After COVID Pause.”

The group discusses how the FDA and other enforcement agencies are starting to return to their pre-COVID agendas – including targeting compliance violations within the life sciences industry.